Skip to main content

AIRDUO RESPICLICK

ICSLABA DPI

Fluticasone propionate / Salmeterol · Teva Pharmaceuticals

Clinical Reference · Data reviewed June 2026

Discontinued by manufacturer

Teva discontinued branded AirDuo RespiClick effective July 9, 2025 (business decision, not safety-related). An identical authorized generic (fluticasone propionate and salmeterol inhalation powder, Teva) remains available in all three strengths.

Teva discontinuation notice

Active Medication & Mechanism

  • Fluticasone propionate ICS
    55 mcg, 113 mcg, or 232 mcg per inhalation

    Synthetic corticosteroid with anti-inflammatory activity. Suppresses inflammatory cells and mediators in the airways.

  • Salmeterol xinafoate LABA
    14 mcg per inhalation

    Long-acting beta2-adrenergic agonist. Stimulates beta2-receptors producing sustained bronchodilation (≥12 hours).

FDA-Approved Dosing — Strength × Indication

55/14 mcg 1 inhalation twice daily (~12 hours apart) → 110/28 mcg
Asthma FDA Approved
For patients not adequately controlled on low-dose ICS.
113/14 mcg 1 inhalation twice daily → 226/28 mcg
Asthma FDA Approved
For patients not adequately controlled on medium-dose ICS.
232/14 mcg 1 inhalation twice daily → 464/28 mcg
Asthma FDA Approved
For patients not adequately controlled on high-dose ICS.

All regimens shown apply to adults (≥18 years) unless otherwise noted · verify against current labelling

Not a rescue inhaler. Not indicated for acute bronchospasm. Use a SABA.

Related Inhalers

For educational reference by healthcare professionals. Not medical advice and not for use in clinical decision-making. This workspace is not a substitute for clinical judgement, prescribing information, or product monographs — always verify doses and indications against the most current labelling. If you are a patient, do not use this site to make medication decisions — speak with your clinician.

Device images are original illustrations for identification aid only — actual devices and packaging may differ. This site is not affiliated with or endorsed by any pharmaceutical manufacturer. Clinical data last reviewed: June 2026.

Inhaler Database · © inhalerdatabase.com 2024–2026 — All rights reserved